PulseAugur
EN
LIVE 18:21:19

FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked

By PulseAugur Editorial · [2 sources] ·

The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the application, which was later reversed after public outcry and internal review. The vaccine has demonstrated superiority over traditional flu vaccines in preventing influenza-like illness, though it may cause more frequent, mild to moderate side effects like injection-site pain and fatigue. AI

IMPACT This approval signifies a broader acceptance and application of mRNA technology beyond COVID-19, potentially accelerating its use in other vaccines and therapeutics.

RANK_REASON FDA approval of a new vaccine technology for a common disease, following regulatory controversy. [lever_c_demoted from significant: ic=2 ai=0.4]

Read on Engadget →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
FDA approval of a new vaccine technology for a common disease, following regulatory controversy. [lever_c_demoted from significant: ic=2 ai=0.4]
Source corroboration
2 independent sources
Multiple independent publishers reporting the same story raises confidence that it's real and newsworthy.
Topics
product, policy
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
51 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [2]

  1. Engadget TIER_1 English(EN) · [email protected] (Steve Dent) ·

    FDA approves Moderna's mRNA flu vaccine after initially refusing to review it

    After refusing to even review it, the FDA has approved Moderna's mRNA seasonal flu vaccine.

  2. Forbes — Innovation TIER_1 English(EN) · Arthur L. Kellermann, Contributor ·

    FDA Approval Of Moderna’s mRNA Flu Vaccine Is Great News. Here’s Why

    The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine to counter any future flu pandemic.

RELATED ENTITIES

RELATED TOPICS